These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31276982)

  • 1. Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease.
    Prokopienko AJ; West RE; Stubbs JR; Nolin TD
    J Pharm Biomed Anal; 2019 Sep; 174():618-624. PubMed ID: 31276982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS/MS: application in assessing peritoneal dialysis.
    Wang Z; Jiang H; Chen X; Song X; Xu F; Chen F; Mao Z; Gao S; Chen W
    J Pharm Biomed Anal; 2020 Jul; 186():113312. PubMed ID: 32361090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
    Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
    Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
    Boelaert J; Lynen F; Glorieux G; Eloot S; Van Landschoot M; Waterloos MA; Sandra P; Vanholder R
    Anal Bioanal Chem; 2013 Feb; 405(6):1937-47. PubMed ID: 23307120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
    André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS.
    Lin CN; Wu IW; Huang YF; Peng SY; Huang YC; Ning HC
    J Food Drug Anal; 2019 Apr; 27(2):502-509. PubMed ID: 30987721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1662-8. PubMed ID: 20036201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a simple UHPLC-MS/MS method for the simultaneous determination of trimethylamine N-oxide, choline, and betaine in human plasma and urine.
    Ocque AJ; Stubbs JR; Nolin TD
    J Pharm Biomed Anal; 2015 May; 109():128-35. PubMed ID: 25767908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
    Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
    J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.
    Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L;
    J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry.
    Amundsen I; Oiestad ÅM; Ekeberg D; Kristoffersen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():112-23. PubMed ID: 23380540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samples.
    Silva LAP; Campagnolo S; Fernandes SR; Marques SS; Barreiros L; Sampaio-Maia B; Segundo MA
    Anal Bioanal Chem; 2023 Feb; 415(4):683-694. PubMed ID: 36464734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of AM80 (tamibarotene) and WJD-A-1 in rat plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
    Leng P; Yang Z; Ma B; Li J; Sun J; Xie Y; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1131-1137. PubMed ID: 29504426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, validation and application of LC-MS/MS method for quantification of amino acids, kynurenine and serotonin in human plasma.
    Virág D; Király M; Drahos L; Édes AE; Gecse K; Bagdy G; Juhász G; Antal I; Klebovich I; Dalmadi Kiss B; Ludányi K
    J Pharm Biomed Anal; 2020 Feb; 180():113018. PubMed ID: 31851908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.
    de Loor H; Meijers BK; Meyer TW; Bammens B; Verbeke K; Dehaen W; Evenepoel P
    J Chromatogr A; 2009 May; 1216(22):4684-8. PubMed ID: 19394619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
    Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
    Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism.
    de Loor H; Poesen R; De Leger W; Dehaen W; Augustijns P; Evenepoel P; Meijers B
    Anal Chim Acta; 2016 Sep; 936():149-56. PubMed ID: 27566350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.